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Institutional report - Coronary
Despite modern off-pump coronary artery bypass grafting women
fare worse than men
Maximilian Y. Emmert , Sacha P. Salzberg *, Burkhardt Seifert , Ulrich P. Schurr , Dragan Odavic ,a,b,1 a,b,1, c b b
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Abstract
Female gender is an established risk factor for worse outcomes after cardiac surgery. Avoiding cardiopulmonary bypass (CPB) for coronary
bypass grafting has an unknown effect on gender differences. Herein, we evaluate if gender has an impact on outcomes after modern off-
pump coronary artery bypass grafting (OPCAB). From 2002 to 2007, we analyzed 983 patients (male: ns807yfemale: ns176) who underwent
OPCAB with symptomatic multi-vessel disease at our institution. The link between gender and outcome was assessed by multivariate
analysis and logistic regression. A composite endpoint was constructed from: 30-day-mortality, renal failure, prolonged intensive care unit
(ICU) stay, neurological complications, use of intra-aortic balloon pump (IABP) and conversion to CPB. Mortality was 3.2% in women vs.1.8%
in men (Ps0.15) and the EuroSCORE was significantly correlated to gender (6.8 vs. 5.2; P-0.001), even after correction (Ps0.036).
Significant more occurrence of the composite endpoint was noted in women (39.8% vs. 29.0%; Ps0.007) whereas for men the risk was
much lower wodds ratio (OR) 0.65; 95% confidence interval (CI) 0.46–0.92; Ps0.015x. For both genders the logistic regression revealed a
risk increase of 15% per one-point-increase of EuroSCORE (corrected) (OR 1.15; 95% CI: 1.10–1.19; P-0.0001). Women had more frequently
a prolonged stay at ICU (Ps0.006) and had a higher stroke rate (2.3% vs. 1.2%; Ps0.29). Complete revascularization was achieved similarly
(95% vs. 94%; Ps0.93). OPCAB offers low mortality and excellent clinical outcome. Women are more likely to experience postoperative
complications. Even if partially neutralized by avoiding CPB, gender differences remain present with modern OPCAB strategies.
 2010 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
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1. Introduction
Coronary artery disease (CAD) is the leading cause of
mortality in women w1x (American Heart Associationy
www.women.americanheart.org). Surgical revascularisa-
tion for CAD remains the treatment of choice in patients
with three-vessel disease, left-main-disease, associated
decreased left ventricular function and diabetes mellitus
w2–4x. Current data report the mortality rate after coronary
artery bypass grafting (CABG) to be significantly increased
in females w5, 6x. Possible causes may be related to later
clinical presentation, worse hemodynamic impairment,
higher age, more incidence of diabetes, more severe heart
disease and particular anatomical considerations, such as
smaller vessel diameter w1x. In addition to this, women
 Presented at the 58th International Congress of the European Society for
CardioVascular Surgery, Warsaw, Poland, April 30–May 2, 2009.
1These authors contributed equally.
*Corresponding author. Department of Cardiovascular Surgery, University
Hospital Zurich, Raemi Street 100, 8091 Zurich, Switzerland. Tel./fax: q41-
44-255 1111.
E-mail address: sacha.salzberg@usz.ch (S.P. Salzberg).
seem to suffer from increased length of intensive care unit
(ICU) stay due to more frequent cardiac low-output states
w6x. Furthermore, especially younger women with myocar-
dial infarction (MI) undergoing CABG represent a particular
high-risk sub-group, as reported by a higher overall mor-
tality w5x. The EuroSCORE (www.euroscore.org) is an estab-
lished score system for preoperative risk stratification in
patients undergoing cardiac surgery. In this risk stratifica-
tion, female gender is an independent risk factor for worse
outcomes after cardiac surgery w7x. Cardiopulmonary bypass
(CPB) is associated with severe complications, such as
stroke, renal dysfunction, low cardiac output, post-
operative bleeding and systemic inflammatory response
syndrome (SIRS). Minimally-invasive approaches to CABG
have led to the development of off-pump coronary artery
bypass grafting (OPCAB) which permits myocardial revas-
cularisation while avoiding CPB. OPCAB remains limited as
clinical acceptance has yet to be achieved. Current data
demonstrate that OPCAB is associated with less complica-
tions and a decrease in mortality w8x. These reports have
not assessed the role of female gender on these outcomes.
Herein, we determine if gender differences remain present
in a modern OPCAB setting.
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Table 1
Preoperative demographics
Parameter Women (ns176) Men (ns807) P-value
Age (years) 66"10 65"10 0.99
EuroSCORE 6.8"3.4 5.2"3.5 -0.001
EuroSCORE (corrected –1) 5.8"3.4 5.2"3.5 0.036
EF (%) 56"17 57"15 0.69
BMI (kgym )2 27"4 27"3 0.85
History of smoking (%) 102 (58) 476 (59) 0.87
Diabetes (%) 47 (27) 194 (24) 0.38
Hypertension (%) 82 (48) 363 (45) 0.86
PAD (%) 19 (11) 89 (11) 1.00
COPD (%) 9 (5) 20 (2.5) 0.14
Positive family history (%) 60 (34) 307 (38) 0.39
Myocardial infarction (-90 days) (%) 67 (38) 323 (40) 0.79
Left main stem disease (%) 62 (35) 282 (35) 1.00
IABP preop (%) 18 (10) 73 (9) 0.89
Elective (%) 121 (68) 525 (65) 0.85
Urgent (%) 35 (20) 202 (25) 0.75
Emergent (%) 21 (12) 80 (10) 0.11
Redo surgery (%) 3 (2) 8 (1) 0.43
EF, ejection fraction; BMI, body mass index; PAD, peripheral artery disease; COPD, chronic obstructive pulmonary disease; IABP, intra-aortic balloon pump.
Table 3
Preoperative laboratory values
Parameter Women (ns176) Men (ns807) P-value
Lc (10 yml)3 8.2"5.6 8.0"3.6 0.65
Hb (gydl) 13.9"1.7 13.8"1.7 0.58
Hk (%) 40.5"4.8 40.5"1.7 0.99
Tc (10 yml)3 266"76 252"71 0.06
Chol (mmolyl) 4.8"1.3 5.2"13.4 0.47
HDL (mmolyl) 1.2"0.3 1.2"0.4 0.80
Tg (mmolyl) 2.0"1.7 1.8"1.5 0.86
CRP (gyl) 12"26 11"26 0.66
Crea (mmolyl) 86"23 88"39 0.77
BNP (ngyl) 281"756 233"464 0.16
Trop T (mgyl) 2.0"7.0 2.4"10.9 0.54
CK (IUyl) 157"294 141"268 0.22
CK-MB (IUyl) 23"32 26"66 0.84
Lc, leukocytes; Hb, haemoglobin; Hk, Haematocrit; Tc, thrombocytes; Chol,
Cholesterine; HDL, high-density lipoprotein; Tg, triglycerides; CRP, C-reac-
tive protein; Crea, creatinine; BNP, B-type natriuretic peptide; Trop T, tro-
ponin T; CK, creatine-kinase; CK-MB, creatine-kinase MB.
Table 2
Preoperative medication
Parameter Women (ns176) Men (ns807) P-value
Heparin (%) 30 (17) 177 (22) 0.15
Aggrastat (%) 26 (15) 145 (18) 0.51
Clopidogrel (%) 16 (9) 57 (7) 0.65
Acetyl salicyl acid (%) 157 (89) 747 (93) 0.65
Others (%) 11 (6) 48 (6) 1.00
ACE inhibitors (%) 26 (15) 121 (15) 1.00
Beta blocker (%) 53 (30) 234 (29) 0.93
2. Methods
From 2002 to 2007, a total of 983 patients underwent
isolated OPCAB for symptomatic multi-vessel disease (MVD)
at our teaching institution. Of these patients, 82% (ns807)
were male and 18% (ns176) female and preoperative risk
was calculated by use of the EuroSCORE risk stratification
system. A database review was performed after approval
by our institutional review board (including a waiver of
signed informed consent). Tables 1–3 resume patients’
demographics, including EuroSCORE, co-morbidities, medi-
cation and preoperative data.
In brief, surgery was performed through a median ster-
notomy and heparin was administered to obtain active
clotting time in excess of 300 s. Epicardial atrial and
sometimes ventricular pacemaker wires were applied. An
octopus (Octopus 4 Tissue-Stabilizer, Medtronic, Minneap-
olis, USA) was used to properly expose the target vessel. A
mister blower (Guidant, Indianapolis, USA) was used to
clear the operating field during anastomosis. Coronary
arteriotomy was performed with a beaver blade and shunt
insertion (ClearView Intracoronary-Shunt, Medtronic, Min-
neapolis, USA) was attempted in all. Proximal anastomosis
was performed in a clamp-less fashion using a heartstring-
device (HEARTSTRING Seal-System, Guidant, Indianapolis,
USA). Revascularization was commenced by left anterior
descending-left internal mammary artery (LAD-LIMA) graft-
ing, after which the right coronary system was approached,
and finally the circumflex territory was done. Hemodyn-
amic optimization was attempted by fluid resuscitation,
Trendelenburg positioning, atrial pacing and catecholamine
administration as a last measure. When still insufficient an
intra-aortic balloon pump (IABP) was placed intra-opera-
tively (ns10, 1%). As an ultimate action, or if necessary,
conversion to CPB was done (ns57; 6%). A beating-heart
procedure was attempted; only in difficult cases cardi-
oplegic arrest was performed.
Continuous data are presented as mean"standard devia-
tion (S.D.) and are compared using the Mann–Whitney test.
Categorical data are presented as number and percentage
and are compared using the x -test or Fisher’s exact test2
where appropriate. A ‘Completeness of Revascularization
Index’ (CRI) was calculated for each patient and was
defined as the total number of distal grafts divided by the
number of the affected coronary vessels reported on the
preoperative coronary angiogram. A composite endpoint
was constructed from: 30-day-mortality, postoperative
renal failure, ICU length of stay (LOS) ()2 days), neurolog-
ical complications, use of IABP and conversion to CPB. A
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Table 4
Composite endpoint and postoperative data
Parameter Women (ns176) Men (ns807) P-value
Composite endpoint (%) 70 (39.8) 234 (29.0) 0.007
Mortality (%) 6 (3.4) 14 (1.7) 0.15
IABP intra-operative (%) 1 (0.6) 9 (1.1) 0.44
CPB conversion (%) 9 (5.1) 48 (5.9) 0.86
Neurological events (central) (%) 4 (2.3) 10 (1.2) 0.29
Neurological events (peripheral) (%) 1 (0.6) 7 (0.9) 1.00
Re-thoracotomy (%) 8 (4.5) 27 (3.3) 0.50
Postoperative creatinine ()220 mmolyl) (%) 1 (0.6) 8 (1.0) 0.51
LOS ICU ()2 days) (%) 48 (27.3) 144 (17.8) 0.006
Ventilation time (h) 12.9"20.8 12.1"13.5 0.30
LOS ICU (days) 2.7"4.9 2.1"3.5 0.011
LOS in-hospital (days) 10.1"5.2 10.2"5.3 0.12
Hb (gydl) (1 day) 10.0"1.4 9.9"1.3 0.50
Hk (%) (1 day) 29.5"4.3 29.0"3.9 0.29
Lc (10 yml) (1 day)3 10.0"3.7 9.9"4.3 0.26
Tc (10 yml) (1 day)3 164"87 182"111 0.037
CK (IUyl) (1 day) 449"559 442"462 0.73
CK-MB (IUyl) (1 day) 27"42 28"42 0.49
Trop T (mgyl) (1 day) 4.4"17.4 5.6"18.7 0.17
Crea (mmolyl) (1 day) 85"25 89"47 0.73
IABP, intra-aortic balloon pump; CPB, cardiopulmonary bypass; LOS, length of stay; ICU, intensive care unit; Lc, leukocytes; Hb, haemoglobin; Hk, haematocrit;
Tc, thrombocytes; Crea, creatinine; Trop T, troponin T; CK, creatine-kinase; CK-MB, creatine-kinase MB.
bivariate logistic regression with gender and a gender
corrected EuroSCORE as covariates was performed to ana-
lyze whether gender is an independent predictor of the
composite endpoint. All analyses were performed using
SPSS13 (SPSS Inc, Chicago, IL, USA). Two-sided P-values
-0.05 are considered statistically significant.
3. Results
The mortality was 2% for all-comers. Females were more
likely to die during the first 30 days when compared to
males (3.4% vs. 1.7%; Ps0.15). Women appeared to have
a higher occurrence of stroke than men (2.3% vs. 1.2%;
Ps0.29) whereas the rate of peripheral neurological com-
plications was similar in both groups (0.6% vs. 0.9%;
Ps1.00). Furthermore, the frequency of re-operation for
bleeding was higher in women, although this did not reach
statistical significance (4.5% vs. 3.3%; Ps0.50). In contrast
to this, it appeared that women experienced a significant
longer stay in the ICU when compared to males
(2.7"4.9 days vs. 2.1"3.5 days; Ps0.011), whereas the
length of hospital stay was quite similar (10.1"5.2 days
vs. 10.2"5.3 days; Ps0.12). Additionally, it became appar-
ent that women had a significantly lower level of platelets
than men (164"87 vs. 182"111; Ps0.037) at the first
postoperative day (Table 4).
Intra-operative insertion of an IABP was necessary in (0.6%
vs. 1.1%; Ps0.44). The rate of conversion to CPB during
the procedure was 5.1% vs. 5.9%; Ps0.86, after conversion
78% vs. 75% were performed beating heart, while 22% vs.
25% underwent aortic cross-clamping. The number of the
diseased coronary vessels were well comparable (2.76"
0.49 vs. 2.79"0.50; Ps0.64). Next, the number of arterial
grafts per patient (1.76"1.05 vs. 1.69"0.94; Ps0.52), the
number of saphenous vein grafts (SVG) per patient
(1.87"1.25 vs. 1.97"1.27; Ps0.29) and the total number
of used grafts per patient were similar among both genders
(3.63"1.03 vs. 3.66"0.96; Ps0.75). In addition to this,
completeness of revascularization was achieved in 95% of
women vs. 94% of men (Ps0.93) and the CRI revealed no
significant differences (1.39"0.67 vs. 1.40"0.63; Ps0.90)
(Table 5).
The EuroSCORE for women was significantly higher than
in men (6.8"3.4 vs. 5.2"3.5; P-0.001). Even the cor-
rected EuroSCORE (EuroSCORE –1) for female gender was
still significantly higher than in men (5.8"3.4 vs. 5.2"3.5;
Ps0.036).
Significantly more occurrence of the composite endpoint
was noted in 40% vs. 29% for women and men (Ps0.007).
These results were mainly driven by the significant longer
stay ()2 days) at the ICU (27% vs. 18%; Ps0.006). Although
the mortality rate (3.4%), the number of central neurolog-
ical complications (2.3%) and the frequency of re-thoracot-
omy (4.5%) were higher in women, these components failed
to reach statistical significance (Table 4). Mean EuroSCORE
(corrected –1) of the affected women was 7.3"3.8 (medi-
an: 7; range: 0–17) vs. 6.3"4.0 (median: 5, range: 0–18)
in men. In the non-affected the EuroSCORE was similar:
4.8"3.0 (median: 4, range: 0–20) vs. 4.7"3.1 (median: 4;
range: 0–18) (Fig. 1).
Female gender was an independent risk factor, as men
had a significantly lower risk for the occurrence of our
composite endpoint. The odds ratio (OR) was 0.65 (95%
confidence interval (CI): 0.46–0.92; Ps0.015). The logistic
regression for both genders revealed a significant risk
increase of 15% per one-point-increase of EuroSCORE (cor-
rected). The OR was 1.15 (95% CI: 1.10–1.19; P-0.0001).
Taken together, these data suggest that a male with a
EuroSCORE of four points might roughly correlate with a
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Table 5
Intraoperative data
Parameter Women (ns176) Men (ns807) P-value
CPB conversion (%) 9 (5.1) 48 (5.9) 0.86
CPB time (min) 93"22 89"27 0.74
Aortic x-clamp time (min) 60"16 58"21 0.69
Arterial grafts per patient 1.76"1.05 1.69"0.94 0.52
LIMA (%) 167 (94.9) 791 (98.0) 0.42
RIMA (%) 83 (47.2) 363 (44.9) 0.62
Radial artery (%) 23 (13.0) 97 (12.0) 0.44
SVG per patient 1.87"1.25 1.97"1.27 0.29
Use of SVG (%) 144 (81.8) 653 (80.9) 0.56
Total number of grafts per patient 3.63"1.03 3.66"0.96 0.75
Number of diseased vessels 2.76"0.49 2.79"0.50 0.64
Completeness of revascularization (%) 167 (94.9) 757 (93.9) 0.93
Completeness of revascularization index (CRI) 1.39"0.67 1.40"0.63 0.90
EC (300 ml per unit) 2.03"4.36 2.17"3.40 0.06
FFP (300 ml per unit) 1.17"2.75 1.12"2.61 0.60
TC (300 ml per unit) 0.22"0.72 0.22"0.78 0.79
CPB, cardiopulmonary bypass; LIMA, left internal mammary artery; RIMA, right internal mammary artery; SVG, saphenous vein graft; EC, erythrocyte concen-
trate; FFP, fresh frozen plasma; TC, thrombocyte concentrate.
Fig. 1. Median EuroSCORE (corrected –1) of the affected women (left col-
umn, right bar) was 7 (range: 0–17) vs. 5, (range 0–18) in men (right column,
right bar); mean: 7.3"3.8 vs. 6.3"4.0. In the non-affected group (left col-
umn and right column, left bar) the median EuroSCORE was similar among
both genders: 4 (0–18) vs. 4 (0–20) (mean: 4.8"3.0 vs. 4.7"3.1).
female having a EuroSCORE (corrected) of two points in
regard to the occurrence of our composite endpoint.
4. Discussion
In our series, it appears that OPCAB offers low mortality
and excellent clinical outcomes for patients requiring myo-
cardial revascularization. However, despite the elimination
of CPB, gender differences in regard to clinical outcomes
remain present and cannot be completely compensated by
the avoidance of CPB. When compared to men, women are
significantly more likely to experience postoperative com-
plications, such as mortality, ICU LOS, neurological compli-
cations, re-operation for bleeding and conversion to CPB.
We believe the significantly decreased postoperative level
of platelets among women might be a plausible explanation
when considering the higher incidence of re-operation for
bleeding. In addition, these findings are clearly confirmed
by a significant lower OR of 0.65 (Ps0.015) for the occur-
rence of our composite endpoint in men.
When taking the EuroSCORE into account we found it
impressive, as even after correction (EuroSCORE –1) women
had a significantly higher EuroSCORE than men (Ps0.036).
We, and others, believe that this highlights the fact that
women may actually suffer from more severe CAD and
worse associated co-morbidities w9x. These co-morbidities
include: age, renal function, pulmonary conditions, periph-
eral vascular disease, neurological dysfunction and
impaired ejection fraction (EF). Furthermore, women have
smaller coronary arteries adding to the operative challenge
when performing OPCAB w1x.
Parallel to this, attention has recently shifted towards
genetic factors which may contribute to worse outcomes
in women. Schuit et al. conducted a prospective cohort
study on postmenopausal women. They looked at MI and
ischemic heart disease (IHD) and analysed the prevalence
of a specific estrogen receptor. Female heterozygous car-
riers of haplotype-1 had an increased risk of MI (event rate:
2.8%; relative ratio (RR) 2.23) compared with non-carriers
(event rate: 1.3%), whereas homozygous carriers had an
increased risk (event-rate: 3.2%; RR: 2.48). For IHD events,
they observed a similar association. In women, the effect
of haplotype-1 on fatal IHD was larger than on non-fatal
IHD. In men, the ESR1 haplotypes were not associated with
an increased risk of MI or IHD. The authors concluded that
postmenopausal women who carry the gene have not only
an increased risk of having an IHD event but also an
increased risk of death from such an event w10x. Regardless
of the surgical approach, these results clearly indicate that
women seem to have a genetic component for worse
outcomes after cardiac surgery and might explain the
significantly increased occurrence of our composite
endpoint.
In contrast to this, Cartier and colleagues prospectively
followed up 1000 OPCAB patients and found that particu-
larly incomplete revascularization (hazard ratio (HR) 2.35),
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multiple internal thoracic artery (MITA) (HR: 0.61), left
ventricular EF (HR: 0.19) and cerebral vascular disease
(HR: 1.50) but not female sex (Ps0.89) were significant
predictors of long-term mortality. They concluded that a
lower survival rate especially observed in younger women
was mostly related to a higher prevalence of preoperative
co-morbidity and a lesser use of MITA grafts than gender
itself w5x. In regard to the long-term outcome the report
also highlights the importance of completeness of revas-
cularization which has often been reported to be limited
in OPCAB w4, 11x. By help of our constructed CRI, we were
able to demonstrate completeness of revascularization for
both genders and could successfully exclude this important
risk factor. This is in line with Puskas et al. who recently
demonstrated feasibility of completeness of revasculariza-
tion in OPCAB w12x. Our results may be explained by our
100% standardized OPCAB approach and especially by the
fact that we perform 95% of all cases in OPCAB fashion
which is far above the international average w11x.
In regard to outcomes when comparing on-pump vs. off-
pump CABG in women, numerous reports are available w13,
14x. Mack et al. reported outcomes on 21,902 consecutive
female patients at 82 institutions undergoing isolated
CABG. Propensity scoring was performed on 7376 women
demonstrating 73% higher mortality (Ps0.002) and a 47%
higher risk of bleeding complications (Ps0.019) in patients
undergoing on-pump CABG. It remains unclear if the avoid-
ance of CPB is the only mechanism involved decreasing
mortality, as the risk profile is essentially the same between
the matched groups reported w13x.
This report clearly indicates a benefit for women under-
going OPCAB and is in line with our overall results that
OPCAB offer low mortality and an excellent clinical out-
come. In comparison, we focussed on the important ques-
tion, if off-pump procedures do also narrow the well
described gender differences after on-pump surgery. In
another large retrospective study, Puskas et al. evaluated
11,413 patients (females: ns3248), comparing OPCAB to
CABG and found that women were older and had higher
predicted risk than males. Among women undergoing CABG
they confirmed an increased OR for death, stroke, MI and
for major cardiac adverse events (MACE). Among women,
OPCAB was associated with a significant risk reduction for
death, stroke and MACE. Moreover, they demonstrated that
women treated with OPCAB had outcomes statistically
similar to men regardless of operative strategy. The authors
concluded that OPCAB is associated with fewer major
adverse cardiac events, narrow gender differences and
even benefits women disproportionately w15x. In contrast
to these data, our results suggest that gender differences
remain present after off-pump procedures. On the other
hand, the univariate analysis of our composite endpoint
components showed that the statistical significance was
mainly driven by the longer stay at the ICU ()2 days).
When excluding this factor, and as all other components
failed to reach statistical significance, they might be par-
tially comparable to their findings w15x.
In conclusion, despite modern OPCAB gender differences
in regard to outcomes and remain present and cannot be
fully compensated by this minimally-invasive approach.
Without a doubt OPCAB seems to benefit women compared
to conventional on-pump CABG. However, it remains
unclear to what extent off-pump procedures narrow these
gender differences. Additional studies are needed to
address this question, particularly since women have always
been under-represented in the current data. Finally, the
suggestion that genetic factors might contribute to worse
outcomes in females has to be recognized and elucidated
in future studies.
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The results of Emmert et al. w1x clearly demonstrate the effect of gender
on postoperative mortality and morbidity. Their analysis of 983 patients
revealed the risk of mortality in females to be 1.8 times that of males.
Furthermore women had a longer ICU stay, a higher stroke rate and were
found to be more likely to develop postoperative complications compared
to the European system for cardiac operative risk evaluation (EuroSCORE)
w2x. Despite performing revascularization using an off-pump technique the
groups results for mortality were significantly greater than the 1% increase
calculated by the EuroSCORE. Other investigators have also found similar
differences. Vaccarino et al. w3x reported in-hospital mortality rates in
women younger than 50 years old three times higher than that of men.
Although alluded to in the article the pathophysiology behind increased
mortality in women remains unclear. Women tend to be older at the time
of surgery with a greater number of co-morbidities. They have smaller
coronary arteries thereby making the task of performing anastomoses more
challenging. Fewer arterial grafts are performed in women, and smaller
chamber volume as well as cardiac mass and circulating volume may reduce
functional reserve to a greater extent compared to men.
We performed coronary revascularization on a male patient who had
undergone bilateral orchidectomy during childhood for undescended testes.
The patient had feminine features of peripheral obesity, lack of facial hair
and gynaecomastia. He was also non-compliant with his testosterone
replacement therapy. During the procedure it was noted that his coronary
arteries were of a smaller diameter and fragile in nature when compared to
an equivalent male patient. The hypothesis was then postulated: should this
patient score an additional point on the EuroSCORE? Clearly this is a rare
occurrence, but should the patient be scored as a woman?
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Coutine Off-Pump Coronary Artery Bypass Grafting
s Safe and Feasible in High-Risk Patients With
eft Main Disease
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hBackground. Coronary artery bypass graft surgery
CABG) remains the method of choice for patients with
eft main disease (LMD). The precise role of off-pump
oronary artery bypass graft surgery (OPCABG) remains
nclear in this setting. We report the safety and feasibil-
ty of a routine OPCABG approach to patients with LMD.
Methods. From 2002 to 2007, 983 patients underwent
yocardial revascularization at our institution. We com-
ared 343 OPCABG patients with LMD (group A) to 640
PCABG patients without LMD (group B). The relation-
hip between the presence of LMD and outcome in
PCABG procedures was statistically assessed. A com-
osite endpoint (30-day mortality, postoperative renal
ailure, intensive care unit length of stay [>2 days],
eurologic complications, use of intra-aortic balloon
ump, and conversion to cardiopulmonary bypass) was
lso used. In addition, completeness of revascularization
as compared in both groups.
Results. Group A had a lower mortality rate (1.7%
ersus 2.2%; p  0.81), and no differences were noted in
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urgery, University Hospital Zurich, Raemi St 100, Zurich 8091, Switzer-
and; e-mail: sacha.salzberg@usz.ch.
2010 by The Society of Thoracic Surgeons
ublished by Elsevier Inconversion to cardiopulmonary bypass (6.7% versus
.3%; p  0.39), intra-aortic balloon pump use (0.3%
ersus 1.4%; p  0.18), and occurrence of composite
ndpoint (30.9% versus 30.8%; p  0.99). The number of
rterial grafts per patient was significantly higher among
atients in group A (1.77  0.95 versus 1.66  0.95; p 
.029) owing to the more frequent use of the right
nternal mammary artery (49.6% versus 42.3%; p  0.031),
hereas the total number of distal anastomoses (3.72 
.90 versus 3.62  1.01; p  0.28) and complete revascu-
arization (94% versus 95%; p  0.55) were similar.
ogistic regression confirmed that LMD is no risk factor
or the occurrence of our composite endpoint (odds ratio
.00; 95% confidence interval: 0.75 to 1.33; p  0.99).
Conclusions. A modern OPCABG approach offers low
ortality, excellent clinical outcomes, and does not come
t the price of less complete revascularization in these
igh-risk patients.
(Ann Thorac Surg 2010;89:1125–30)
© 2010 by The Society of Thoracic Surgeonseft main coronary artery disease (LMD) is a well-
established risk factor for cardiac-related adverse
vents [1–5] and is generally associated with a higher
alcific load of the aorta and other peripheral arteries
6, 7]. As implemented in the commonly accepted guide-
ines of the American Heart Association (with a level of
vidence: A), coronary artery bypass graft surgery (CABG)
emains the method of choice for patients with LMD [8].
Cardiopulmonary bypass (CBP) is associated with seri-
us complications such as low cardiac output, stroke, post-
perative bleeding, renal dysfunction, and systemic inflam-
atory response syndrome [9, 10]. Minimally invasive
echniques for CABG have led to the development of
ff-pump coronary artery bypass grafting (OPCABG),
hich permits myocardial revascularization while avoiding
PB.
Current data demonstrate that OPCABG is associated
ccepted for publication Dec 18, 2009.
ddress correspondence to Dr Salzberg, Department of Cardiovascularith fewer major complications and a decrease of risk-
djusted mortality in general [11–17]. However, as it is
racticed today, OPCABG remains debated, as overall
linical acceptance has yet to be achieved. In addition to
emporary stabilization, off-pump procedures involve
epetitive mobilization of the heart, especially when the
ircumflex territory is addressed. In addition to this,
rolonged phases of hypotension and decreased cardiac
utput may compromise hemodynamics [18, 19]. For
hese reasons, surgeons have been cautious so far to
xpose patients with significant LMD to these tech-
iques, for fear of emergent conversion to CPB.
The aim of this study was to evaluate the safety and
easibility of a routine OPCABG approach to patients with
MD.
aterial and Methods
etween 2002 and 2007, a total of 983 patients underwent
solated OPCABG for symptomatic coronary artery dis-
ase (CAD) at our institution. A single-center retrospec-
ive database analysis was conducted after approval by
0003-4975/10/$36.00
doi:10.1016/j.athoracsur.2009.12.059
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Cur local Institutional Review Board, including a waiver
f informed consent. We compared 343 OPCABG pa-
ients with LMD (group A) and 640 patients without LMD
group B). The LMD was defined as stenosis of the main
tem of the left coronary artery of more than 50%. Of
hese patients, 81.2% (n  799) were male and 18.2% (n 
84) were female. Surgery was performed as follows:
lective (69%; n  679), urgent (22%; n  217) and
mergent (9%, n  87). Reoperative cases other than
revious CABG were done in 1% of cases, and 9% of all
atients (n  92) required preoperative implantation of
n intra-aortic balloon pump (IABP). Mean preoperative
isk stratification was done by use of the European System
or Cardiac Operative Risk Evaluation (EuroSCORE) risk
tratification system. Table 1 and 2 summarize patient’s
emographics, including EuroSCORE, comorbidities,
ype of medication, and preoperative data.
All OPCABG procedures were performed through a
edian sternotomy. Internal mammary artery harvest
as skeletonized, and all other grafts where endoscopi-
ally harvested (including radial artery). Cardiac expo-
ure was obtained by four pericardial stay sutures. The
ericardium was opened in a T fashion. Heparin was
dministered to obtain activated clotting time in excess of
00 s, and repeated if necessary. Epicardial atrial and
entricular temporary pacemaker wires were adminis-
ered to all patients. Cardiac positioning was first done
ith rolled up surgical swabs; after this an Octopus
able 1. Preoperative Demographics
ariable
Group A
LMD
n  343
Group B
Non-LMD
n  640
p
Value
ge, years 66 10 65  10 0.29
ale (%) 281 (82) 518 (81) 0.76
emale (%) 62 (18) 122 (19) 0.69
uroSCORE 5.5  3.6 5.5  3.5 0.96
jection fraction, % 57 15 56  16 0.24
ody mass index, kg/m2 27  4 27  3 0.92
istory of smoking (%) 195 (57) 378 (59) 0.45
iabetes mellitus (%) 89 (26) 154 (24) 0.48
ypertension (%) 165 (48) 288 (45) 0.86
eripheral artery disease (%) 38 (11) 77 (12) 0.59
OPD (%) 7 (2) 19 (3) 0.55
ositive family history (%) 127 (37) 237 (37) 1.00
yocardial infarction, 90
days (%)
145 (42) 243 (38) 0.24
ABP preoperatively (%) 38 (11) 51 (8) 0.20
lective (%) 199 (58) 397 (62) 0.82
rgent (%) 96 (28) 179 (28) 0.93
mergent (%) 48 (14) 64 (10) 0.38
edo surgery (%) 7 (2) 6 (1) 0.20
roponin T, g/L 3.6  11.9 1.7  3.6 0.20
reatine kinase, IU/L 185 368 119  182 0.57
reatine kinase-MB, IU/L 25 38 25  32 0.14
OPD  chronic obstructive pulmonary disease; EuroSCORE  Eu-g
opean System for Cardiac Operative Risk Evaluation; IABP  intra-
ortic balloon pump; LMD  left main disease.Octopus 4 Tissue Stabilizer; Medtronic, Minneapolis,
N) was used to properly expose the target vessel. In
elected cases, the right pleural space was widely opened
o allow cardiac positioning into the right side of the
hest for better exposition of the circumflex artery terri-
ory. Additionally, a mister blower (Guidant, Indianapo-
is, IN) was used. Coronary arteriotomy was performed
ith a beaver blade, and shunt insertion (ClearView
ntracoronary Shunt; Medtronic) was used whenever
ossible. Anastomosis was performed with polypro-
ylene 8-0 suture for all arterial anastomosis and
olypropylene 7-0 running suture when a venous graft
as used. Proximal anastomosis was performed in a
lampless fashion (“no touch” technique for proximal
nastomosis) using the Heartstring device (Heartstring
roximal Seal System; Guidant) with 6-0 polypropylene.
low was measured using the MediStim Quick Fit ultra-
ound probes (MediStim, Nydalen, Norway) in all cases.
f insufficient flow was documented (flow 5 mL/min
r pulsatility index 4) [20, 21], the anastomosis was
epeated.
Surgical revascularization was started by left anterior
escending to left internal mammary artery grafting.
fter this, the right coronary system was approached,
nd finally the circumflex territory was revascularized. In
atients with LMD, left anterior descending and circum-
ex arteries were always grafted, regardless of the degree
f stenosis. All other vessels with significant lesions
70%) were identified preoperatively in the angiogram
nd selected as target for revascularization.
In all cases, hemodynamic optimization was attempted
y volume management, Trendelenburg positioning,
trial pacing and catecholamine administration. If this
onservative approach was insufficient, an IABP was
nserted intraoperatively. If the patient remained unsta-
le under IABP support, conversion to CPB was done.
efore nonemergent conversion, transesophageal echo-
ardiography and pulmonary artery catheter (Swan-
anz catheter) analysis were used to evaluate hemody-
amic instability. Emergent conversion to CPB was
voided, and a beating heart procedure was attempted
henever possible. Only in difficult cases was cardiople-
able 2. Preoperative Medication
edication
Group A
LMD
n  343
Group B
Non-LMD
n  640
p
Value
iquemin (%) 82 (24) 126 (20) 0.14
ggrastat (%) 65 (19) 106 (17) 0.38
lavix (%) 22 (6) 58 (9) 0.18
spirin (%) 319 (93) 569 (89) 0.41
thers (%) 24 (7) 34 (5) 0.32
CE inhibitors (%) 55 (16) 93 (15) 0.58
eta-blocker (%) 117 (34) 169 (26) 0.012
CE  angiotensin-converting enzyme; LMD  left main disease.ic arrest performed.
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Ctatistical Analysis
ontinuous data are presented as mean  SD and are
ompared using the Mann-Whitney U test. Categorical
ata are presented as number and percentage and are
ompared using the 2 test or Fisher’s exact test where
ppropriate. A completeness of revascularization index
as calculated for each patient. The completeness of
evascularization index was defined as the total number
f distal grafts divided by the number of the affected
oronary vessels reported on the preoperative coronary
ngiogram. A composite endpoint was constructed from
he following: 30-day mortality, postoperative renal fail-
re, intensive care unit length of stay of more than 2 days,
se of IABP, conversion to CPB, and central neurologic
omplications. Central neurologic complications were
ivided into permanent central complications such as
troke, and temporary complications (1 to 7 days) such as
ostoperative delirium. Logistic regression was per-
ormed to analyze whether LMD is an independent
redictor of the composite endpoint. All analyses were
erformed using SPSS 13 (SPSS Inc., Chicago, IL). All
values less than 0.05 are assumed to be statistically
ignificant.
esults
emographics and Preoperative Data
atients with LMD (group A; n  343) and patients
ithout LMD (group B; n 640) were comparable in age,
ex, comorbidities, cardiovascular risk factors, preopera-
ive medication, and laboratory variables (Tables 1 and
). Although not being significant, impaired cardiac con-
itions such as recent myocardial infarction (within the
ast 90 days [41.8% versus 37.9%; p  0.24]), preoperative
mplantation of an IABP (11.1% versus 8.4%; p  0.20),
nd an increased rate of high-risk reoperation (1.7%
ersus 0.8%; p  0.20) appeared to be more frequent in
roup A. Similarly, patients with LMD had a higher level
f preoperative cardiac enzymes such as troponin-T,
reatine kinase, and creatine kinase–myocardial band.
he EuroSCORE (5.6  3.5 versus 5.5  3.6; p  0.96) and
he preoperative ejection fraction (56 15 versus 58 15;
 0.24) were similar in both groups.
ntraoperative Data
n group A, the number of arterial grafts per patient was
ignificantly higher (1.77  0.95 versus 1.66  0.95; p 
.029) after the more frequent use of the right internal
ammary artery (49.6% versus 42.3%; p  0.031; Table 3).
he left internal mammary artery, the radial artery, and
aphenous vein grafts were used similarly frequent in
oth groups. In regard to saphenous vein grafts, each
atient in group A received 1.95  1.29 versus 1.96  1.25
n group B (p  0.87). Taken together, the total number of
sed grafts (arterial and venous) per patient was similar
n both groups (3.72  0.90 versus 3.62  1.01; p  0.28).
ompleteness of revascularization was achieved in 94%
f patients in group A and in 95% of patients in group B
p  0.55), and the completeness of revascularization wndex revealed no significant differences (1.44  0.66
ersus 1.39  0.65; p  0.26). Although conversion to CPB
as more frequently necessary in group A (6.7% versus
.3%; p 0.39; conversion rate for whole series: 5.9%, n
7), this failed to reach statistical significance. If con-
erted to CPB, duration and cross-clamping time were
imilar in both groups.
ortality, Composite Endpoint, and Logistic
egression
here was no statistical difference in regard to 30-day
ortality (1.7% versus 2.2%; p  0.81) and postoperative
omplications, such as stroke rate (0.6% versus 1.9%; p 
.16; total stroke rate for whole series: 1.4%, n  14),
emporary central neurologic dysfunction (postoperative
elirium) or peripheral neurologic complications (Table 4).
imilarly, there were no differences in regard to postop-
rative increased creatinine levels (220 mol/L), the
ength of stay at the intensive care unit, and the length of
ospitalization. In contrast to this, the rate of rethora-
otomy was higher in group A (5.2% versus 2.7%; p 
.46), but failed to reach statistical significance. In sum-
ary, all components of our composite endpoint did not
how any statistical difference, and its occurrence was
ery similar in both groups (30.9% versus 30.8%; p 
.99). Next, the logistic regression confirmed that LMD is
o risk factor for the occurrence of our composite end-
oint. The odds ratio was 1.00 (95% confidence interval:
.75 to 1.33; p  0.99). The result remained unchanged
able 3. Intraoperative Data
ariable
Group A
LMD
n  343
Group B
Non-LMD
n  640
p
Value
PB conversion, n (%) 23 (6.7) 34 (5.3) 0.39
PB time, minutes 87  41 97 34 0.35
ortic cross-clamp time,
minutes
70  39 55 10 0.44
rterial grafts per patient 1.77  0.95 1.66 0.95 0.029
IMA, n (%) 332 (96.8) 624 (97.5) 0.54
IMA, n (%) 170 (49.6) 271 (42.3) 0.031
adial artery, n (%) 39 (11.4) 78 (12.2) 0.76
VG per patient 1.95  1.29 1.96 1.25 0.87
se of SVG, n (%) 284 (82.8) 531 (83.0) 0.62
otal number of grafts
per patient
3.72  0.90 3.62 1.01 0.28
umber of diseased
vessels
2.77  0.50 2.78 0.50 0.83
ompleteness of
revascularization, n (%)
323 (94.2) 608 (95.0) 0.55
ompleteness of
revascularization index
1.44  0.66 1.39 0.65 0.26
C (300 mL per unit) 2.13 3.66 2.16 3.49 0.64
FP (300 mL per unit) 1.21 2.76 1.19 2.40 0.47
C (300 mL per unit) 0.20 0.78 0.24 0.75 0.35
PB  cardiopulmonary bypass; EC  erythrocyte concentrates;
FP  fresh frozen plasma; LIMA  left internal mammary artery;
MD  left main disease; RIMA  right internal mammary artery;
VG  saphenous vein graft; TC  thrombocyte concentrates.hen the odds ratio was adjusted for the EuroSCORE.
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Comment
n our series, it appears that OPCABG offers low mortal-
ty and an excellent clinical outcome for patients with
MD. In regard to major morbidity and mortality, we did
ot detect any significant differences between both
roups when analyzing single outcome parameters. Fur-
hermore, in this large population, the construction of a
omposite endpoint also failed to yield any difference.
ogistic regression revealed an odds ratio of 1 with a
arrow confidence interval and thus confirmed that LMD
s no risk factor for the occurrence of the composite
ndpoint. Taken together, our data suggest that patients
ith LMD may safely undergo modern OPCABG
rocedures.
Many reports seem to indicate that OPCABG is asso-
iated with decreased mortality and overall complication
ates [11–16], and although the OPCABG practice is being
ore widely accepted [22], OPCABG for high-risk pa-
ients with LMD remains controversial. Left main disease
s a well-established risk factor related to cardiac adverse
vents [3–5], and its presence often deters a surgeon from
erforming OPCABG. Additionally, few data in regard to
afety and outcomes of these high-risk patients are
able 4. Composite Endpoint and Postoperative Data
ariable
Group A
LMD
n  343
Group B
Non-LMD
n  640
p
Value
omposite endpoint (%) 106 (30.9) 198 (30.8) 0.99
ortality (%) 6 (1.7) 14 (2.2) 0.81
ABP intraoperative (%) 1 (0.3) 9 (1.4) 0.18
PB conversion (%) 23 (6.7) 34 (5.3) 0.39
eurologic events (central),
permanent (%)
2 (0.6) 12 (1.9) 0.16
eurologic dysfunction
(central), temporary (%)
12 (3.5) 24 (3.8) 0.52
eurologic events (peripheral),
permanent (%)
3 (0.9) 5 (0.8) 1.00
ethoracotomy (%) 18 (5.2) 17 (2.7) 0.46
ostoperative creatinine, 220
umol/L (%)
1 (0.3) 8 (1.3) 0.17
OS ICU 2 days (%) 61 (17.8) 131 (20.5) 0.35
espirator time, hours 12.2 12.6 12.3  16.2 0.82
OS ICU, days 2.0  3.0 2.3  4.2 0.55
OS hospital, days 9.9  4.6 10.3  5.6 0.42
emoglobin, g/dL, 1 day 10.0 1.5 9.9  1.3 0.36
ematocrit, %, 1 day 29.5  4.3 29.0  3.9 0.22
eukocytes, 103/uL, 1 day 10.0  3.2 9.9  5.2 0.24
hrombocytes, 103/uL, 1 day 164  90 169  94 0.79
reatine kinase, IU/L, 1 day 455 451 436  495 0.24
reatine kinase-MB, IU/L,
1 day
27  32 29  47 0.92
roponin T, g/L, 1 day 5.3  16.0 5.4  19.0 0.45
reatinine, mol/L, 1 day 87 33 89  49 0.98
PB  cardiopulmonary bypass; IABP  intra-aortic balloon pump;
CU  intensive care unit; LMD  left main disease; LOS 
ength of stay.vailable [2, 23–27]. aOur results are supported by Dewey and colleagues
23], who compared 823 patients undergoing surgical
evascularization with LMD. One hundred of these pa-
ients underwent an off-pump procedure, and 723 pa-
ients underwent the conventional CABG. The authors
ound a mortality rate of 1% versus 4.7% (p  0.059) in
avor of OPCABG and concluded that OPCABG is a safe
nd feasible option for patients with LMD. In another
tudy, Yeatman and colleagues [26] reported 387 patients
ndergoing either OPCABG or CABG for LMD. They
isplayed lower requirements for inotropes, less transfu-
ion requirement, and a slightly shorter hospital stay, but
t the price of less complete revascularization. Owing
o similar mortality rates in both groups, they found
PCABG to be efficient for patients with LMD at the cost
f a less complete revascularization [26]. Next, Virani and
oworkers [25] compared 95 patients with LMD. Of these
atients, 73 underwent OPCABG and 22 underwent
evascularization using CPB. These investigators found a
ignificantly lower number of used grafts within the
PCABG group. The mortality rate was similar, and the
ean hospital length of stay was significantly lower in
he OPCABG group. The authors concluded that patients
ith LMD can undergo OPCABG grafting safely, and
uggested that LMD should no longer be seen as a
ontraindication to perform OPCABG [25].
In summary, these reports clearly indicate feasibility
nd safety of an OPCABG approach to high-risk patients
ith LMD. In comparison with these groups comparing
PCABG versus on-pump CABG, we focused on the
mportant question of whether the presence of LMD
ffects the outcome within an OPCABG cohort. Further-
ore, our subgroup with LMD was much larger than the
ize of the reported study populations. More similar to
ur study size, Lu and associates [2] evaluated 1,197
atients with LMD, of whom 259 underwent the off-
ump approach versus 938 who had on-pump surgery.
he authors detected comparable outcomes, but also
ound the OPCABG approach to be associated with
ignificantly less complete revascularization [2].
In contrast to these reports, we were able to demon-
trate completeness of revascularization as an important
redictor for the long-term outcome and often reported
o be a limiting factor when performing OPCABG [26, 28,
9]. Our constructed completeness of revascularization
ndex revealed that complete revascularization was suc-
essfully achieved in almost 95% of our patients, suffi-
iently excluding this important risk factor. Moreover,
he comparison between patients with LMD (group A)
nd without LMD (group B) showed no significant dif-
erence in regard to the total number of received grafts
er patient and the constructed completeness of revas-
ularization index. In contrast to other available reports
2, 23, 25, 26], our data suggest that performing OPCABG
n patients with LMD was not at cost of complete revas-
ularization in our series.
These important findings are supported by Puskas and
olleagues [16] who recently demonstrated the feasibility
f completeness of revascularization in OPCABG. The
uthors prospectively compared 200 unselected patients
u
s
f
v
s
h
e
a
i
O
a
[
o
h
p
f
e
c
t
p
d
e
m
d
a
t
r
a
m
a
b
s
a
r
t
e
s
l
a
c
t
t
F
b
a
l
fi
r
a
w
s
m
r
e
p
r
S
O
d
o
t
a
t
s
l
e
a
l
w
o
c
R
1
1
1
1
1129Ann Thorac Surg EMMERT ET AL
2010;89:1125–30 OFF-PUMP SURGERY IS SAFE IN LEFT MAIN DISEASE
A
D
U
LT
C
A
R
D
IA
Cndergoing either OPCABG or conventional on-pump
urgery. When compared with on-pump surgery, they
ound OPCABG to achieve similar completeness of re-
ascularization [16]. In comparison to that study, our data
how that complete revascularization is even possible in
igh-risk patients with LMD. This finding might be
xplained by our 100% standardized OPCABG approach,
nd especially by the vast OPCABG experience of our
nstitution because 95% of all cases are performed in
PCABG fashion, which is far above the international
verage [29].
In another interesting trial, Muneretto and associates
27] prospectively compared 88 OPCABG patients and 88
n-pump patients. In their series, they were even able to
ighlight complete revascularization among off-pump
atients by only using arterial grafts. Additionally, they
ound comparable mortality rates, but decreased postop-
rative morbidity rates among off-pump patients. They
oncluded that OPCABG could be successfully used for
otal arterial grafting without compromising the com-
leteness of revascularization and that avoidance of car-
iopulmonary bypass is associated with reduced postop-
rative morbidity [27].
Steed and colleagues [30] analyzed the underlying
echanisms and displayed marked subendocardial un-
erperfusion during bypass [30]. Furthermore, Akins and
ssociates [31] demonstrated preservation of interven-
ricular septal function in patients having coronary artery
evascularization without CPB. Taken together and as
lso demonstrated by the postoperative cardiac enzymatic
arkers (creatine kinase, creatine kinase–myocardial band,
nd troponin-T), which were similar in both groups, we
elieve that the OPCABG approach reduces myocardial
tress during the procedure, hence eliminating the neg-
tive effect of LMD on outcomes.
In general, the efficacy of OPCABG surgery for high-
isk patients with LMD could only be established owing
o continuously improving surgical techniques and well-
stablished intraoperative strategies. At our institution,
urgical revascularization was standardized, starting with
eft anterior descending artery to left internal mammary
rtery grafting to preserve myocardial supply during
ardiac torsion and proximal occlusion procedures. Then
he right coronary system was approached, and finally
he posterior aspect of the heart was revascularized.
urthermore, shunt insertion was done whenever possi-
le to maintain distal perfusion during the procedure. In
prospective, randomized trial, Vassiliades and col-
eagues [32] recently highlighted the importance of suf-
cient distal perfusion during OPCABG procedures in
egard to the postoperative cardiac function. Finally, our
pplied no-touch technique for proximal anastomosis
as confirmed by a very low stroke rate for our entire
eries.
In conclusion, it appears that OPCABG offers a low
ortality rate and excellent clinical outcome for patients
equiring isolated myocardial revascularization. A mod-
rn OPCABG approach is safe and feasible for high-risk
atients with LMD, and not at the cost of less complete
evascularization.
1tudy Limitations
f course, this is a retrospective study and all associated
isadvantages apply. An ideal approach would be a trial
f prospective and randomized nature. However, so far
hese trials are only available for OPCABG patients with
relatively low risk profile [15, 33]. Next, our results lack
he force of numbers, and certainly a higher level of
ignificance may have been obtained had we analyzed a
arger cohort of patients. However, we present a homog-
nous population with a 100% standardized and modern
pproach to OPCABG. This approach is supported by at
east 95% of CABG cases being done in off-pump fashion,
hich is far above the international standard, and also by
ur excellent overall outcome as well as our overall low
onversion rate to CPB.
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